Quick Answer
CervoMed Inc. reported Stockholders Equity of $18.22 million for the year ending 2025.
- CervoMed Inc. showed a decrease of -53.5% in Stockholders Equity from 2024 to 2025.
- This data is from CervoMed Inc.'s annual report (Form 10-K), filed with the SEC on March 13, 2026.
- XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2010: $20.2 thousand | Q2 2011: $8.65 million | Q3 2011: $5.05 million | Q4 2011: -$143.4 thousand | Q3 2012: -$6.03 million | Q4 2012: -$18.39 million | Q2 2013: -$8.54 million | Q3 2013: -$6.29 million | Q1 2014: $12.22 million | Q2 2014: $45.30 million | Q3 2014: $42.80 million | Q1 2016: $16.58 million | Q2 2016: $14.03 million | Q3 2016: $11.49 million | Q1 2017: -$19.12 million | Q2 2017: $1.17 million | Q3 2017: $6.36 million | Q1 2018: $29.72 million | Q2 2018: $27.30 million | Q3 2018: $20.91 million | Q1 2019: $12.95 million | Q2 2019: $16.18 million | Q3 2019: $13.52 million | Q1 2020: $17.90 million | Q2 2020: $32.88 million | Q3 2020: $28.72 million | Q4 2020: $24.81 million | Q1 2021: $53.65 million | Q2 2021: $50.17 million | Q3 2021: $38.13 million | Q1 2022: $30.62 million | Q2 2022: $26.67 million | Q3 2022: $24.05 million | Q1 2023: -$33.75 million | Q2 2023: -$35.11 million | Q3 2023: $9.57 million | Q1 2024: $5.34 million | Q2 2024: $49.98 million | Q3 2024: $45.64 million | Q1 2025: $34.63 million | Q2 2025: $33.44 million | Q3 2025: $26.01 million.
- Over the full 13 years of available data (2013 to 2025), CervoMed Inc.'s Stockholders Equity has grown by 182.1%.
- Historical annual values: Fiscal year 2025: $18.22 million | Fiscal year 2024: $39.20 million | Fiscal year 2023: $7.38 million | Fiscal year 2022: -$33.29 million | Fiscal year 2021: $34.91 million | Fiscal year 2020: $24.81 million | Fiscal year 2019: $20.13 million | Fiscal year 2018: $15.61 million | Fiscal year 2017: $21.23 million | Fiscal year 2016: $9.18 million | Fiscal year 2015: -$41.6 thousand | Fiscal year 2014: $38.17 million | Fiscal year 2013: $6.46 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: